|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003250,
umls-concept:C0010803,
umls-concept:C0020792,
umls-concept:C0024204,
umls-concept:C0038952,
umls-concept:C0205262,
umls-concept:C0281345,
umls-concept:C0442135,
umls-concept:C0443252,
umls-concept:C1446468,
umls-concept:C1513276,
umls-concept:C1516213,
umls-concept:C1527249,
umls-concept:C1707520
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1994-3-8
|
|
pubmed:abstractText |
Patients with transmurally invasive, lymph node negative colorectal carcinoma (Dukes' B) have a 5-year survival rate ranging from 53.9% to 84.9%. The authors postulate that patients with Dukes' B colon cancer who die of their disease have occult micrometastases in their pericolic lymph nodes at the time of original diagnosis. In an attempt to identify these occult micrometastases, pericolic lymph nodes from Dukes' B colon cancer resections were stained retrospectively with antibodies against cytokeratin (anti-keratin AE1/AE3, Boehringer Mannheim, Indianapolis, IN) and CC49 (a second-generation monoclonal antibody directed against TAG-72.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
563-9
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7507795-Antibodies, Monoclonal,
pubmed-meshheading:7507795-Antigens, Neoplasm,
pubmed-meshheading:7507795-Colorectal Neoplasms,
pubmed-meshheading:7507795-Glycoproteins,
pubmed-meshheading:7507795-Humans,
pubmed-meshheading:7507795-Immunohistochemistry,
pubmed-meshheading:7507795-Keratins,
pubmed-meshheading:7507795-Lymph Nodes,
pubmed-meshheading:7507795-Lymphatic Metastasis,
pubmed-meshheading:7507795-Prognosis,
pubmed-meshheading:7507795-Retrospective Studies,
pubmed-meshheading:7507795-Survival Rate
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
|
|
pubmed:affiliation |
Department of Pathology, Ohio State University Hospitals, Columbus.
|
|
pubmed:publicationType |
Journal Article
|
